Flyte Aviation’s LockeT shows fewer complications than Abbott’s Perclose in clinical study
VJET•A 172-patient comparative study found fewer access-site complications with Flyte Aviation’s LockeT than with Abbott’s Perclose; LockeT had no device failures, while bleeding-control times and same-day discharge rates were similar.
1. Study results
Catheter Precision announced publication of a 172-patient comparative study showing fewer access-site complications with LockeT than with Abbott’s Perclose. LockeT recorded no device failures, while Perclose had failures. Both devices showed similar bleeding-control times and same-day discharge rates.
